참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Benzimidazole | HCID 5798 | — |
| 반응물 | Triphenylphosphine | HCID 11776 | — |
| 반응물 | 4-bromo-N-(1,3-thiazol-2-yl)benzene-1-sulfonamide | HCID 669304 | — |
| 촉매 | Copper iodide | HCID 83717 | — |
| 촉매 | palladium(II) acetate | HCID 167845 | — |
| 용매 | Acetone | HCID 180 | — |
| 용매 | 1,4-Dioxane | HCID 31275 | — |
| 생성물 | 4-(1H-Benzimidazol-2-yl)-N-(1,3-thiazol-2-yl)benzene-1-sulfonamide | HCID 16039933 | 2.2% |
반응 단계
Benzimidazole (0.313 mmol) and MgO (0.376 mmol) was stirred in 1,4-dioxane (2 mL) for 10 min. at room temp. To the solution, copper iodide (0.627 mmol), palladium acetate (0.016 mmol), triphenylphosphine (0.062 mmol), and 4-bromo-N-thiazol-2-yl-benzenesulfonamide (0.313 mmol) were added. The reaction was sealed and heated to 150° C. After 7 h the reaction was cooled to 120° C. and stirred overnight. The reaction was cooled to room temperature and diluted with acetone. The solution was filtered through Celite and concentrated in vacuo. The crude was purified by reverse phase chromatography to yield 4-(1H-benzoimidazol-2-yl)-N-thiazol-2-yl-benzenesulfonamide (0.007 mmol).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07615569B2 |
|---|
| 출처 데이터셋 | uspto-grants-2009_11 |
|---|
| ORD ID | ord-11b19ce5401e465389a45aed940ef3c2 |
|---|
| 출처 메모 | uspto-grants-2009_11 |
|---|